Omega Fund Management’s Cidara Therapeutics CDTX Stock Holding History

Omega Fund Management’s Portfolio CDTX Stock Details CDTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-100,262	Closed	-$4.49M	–	24
2021 Q3	$4.49M	Hold	100,262	–	–	0.5%	20
2021 Q2	$4.05M	Hold	100,262	–	–	0.46%	18
2021 Q1	$5.33M	Hold	100,262	–	–	0.5%	17
2020 Q4	$4.01M	Hold	100,262	–	–	0.6%	15
2020 Q3	$5.71M	Hold	100,262	–	–	1.55%	10
2020 Q2	$7.4M	Sell	100,262 -146	-0.1%	-$9.46K	2.02%	10
2020 Q1	$4.98M	Buy	100,408 +18,382	+22%	+$1.1M	2.06%	10
2019 Q4	$6.3M	Hold	82,026	–	–	2.01%	9
2019 Q3	$3.27M	Buy	82,026 +6,586	+9%	+$221K	1.01%	12
2019 Q2	$2.54M	Hold	75,440	–	–	0.65%	14
2019 Q1	$4M	Hold	75,440	–	–	1.28%	8
2018 Q4	$3.55M	Hold	75,440	–	–	2.63%	8
2018 Q3	$6.64M	Hold	75,440	–	–	3.14%	8
2018 Q2	$7.85M	Buy	75,440 +53,192	+239%	+$5.02M	5.79%	7
2018 Q1	$1.78M	Hold	22,248	–	–	1.75%	11
2017 Q4	$3.03M	Hold	22,248	–	–	2.19%	9
2017 Q3	$3.6M	Hold	22,248	–	–	2.04%	9
2017 Q2	$3.34M	Hold	22,248	–	–	2.08%	8
2017 Q1	$3.47M	Sell	22,248 -2,505	-10%	-$440K	2.26%	9
2016 Q4	$5.15M	Buy	+24,753	New	+$5.14M	4.18%	6

Other funds holding CDTX

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return

ACM

Alethea Capital Management Mercer Island, Washington $241M AUM 112.74% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

5VM

5AM Venture Management San Francisco, California $288M AUM 313.93% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Omega Fund Management's CDTX Position: Q4 2021 in Review

Omega Fund Management sold out of Cidara Therapeutics (CDTX) in Q4 2021, closing a stake of 100,262 shares — an estimated $4.49M sold.

Omega Fund Management first reported a position in CDTX in Q4 2016 and held it in 20 quarters. The position peaked at $7.85M in Q2 2018. 52 funds tracked by Wall St. Rank hold CDTX as of Q4 2021.

Omega Fund Management reported no remaining Cidara Therapeutics position as of Q4 2021 after selling out during the quarter.
Omega Fund Management sold 100,262 Cidara Therapeutics shares in Q4 2021, an estimated $4.49M.
Omega Fund Management first reported a position in Cidara Therapeutics in Q4 2016 and held it in 20 quarters.
Omega Fund Management's Cidara Therapeutics position peaked at $7.85M in Q2 2018.
52 funds tracked by Wall St. Rank held Cidara Therapeutics as of Q4 2021.

Based on Omega Fund Management's 13F filing for Q4 2021, filed 14 Feb 2022.